📰 Rhinitis News
Page 2 - Rhinitis News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Rhinitis. Real-time updates on events, politics, business and more.
September 15, 2023
A relaxed approach to maintenance therapy during the summer likely contributes to the surge in emergency department admissions for asthma that follows the reopening of schools.
August 30, 2023
The association between the maturation of the infant gut microbiome and the infant immune system.
August 17, 2023
Researchers used human transcriptomic data to differentiate the molecular mechanisms associated with two phenotypes of allergic rhinitis: rhinitis and rhinitis with asthma.
July 25, 2023
In the largest study of its kind, researchers from Children's Hospital of Philadelphia (CHOP) used electronic health record (EHR) data from more than 200,000 pediatric patients to describe patterns of pediatric allergies across the United States, validating a population-level pattern of allergy development known as the "allergic march," in which allergies first present as eczema, followed by food allergies, asthma, and environmental allergies.
June 25, 2023
Post-nasal drip occurs as dripping of the excessive mucus from the nasal mucosa caused by allergy or infection. Post-nasal drip can cause bad breath and snoring.
June 8, 2023
Primary and all key secondary confirmatory endpoints were met, with an improvement in the total combined allergic rhinitis score of 22% compared to placebo . Results were highly statistically... | June 8, 2023
June 7, 2023
Benralizumab is a highly effective biologic for the management of severe eosinophil asthma.
June 1, 2023
Researchers evaluated titers and types of severe acute respiratory syndrome coronavirus 2 antibodies in voluntary blood donors.
May 22, 2023
Research paper highlights the importance of a diverse and balanced gut microbiota for human health, while emphasizing the need for further understanding of the impact of indoor microbiome and metabolites on gut microbiota.
May 22, 2023
The French EfficAPSI study confirmed that sublingual liquid immunotherapy or "desensitization" reduces the risks for asthma onset and the worsening of asthma in patients with allergic rhinitis.